Manufacturer record
Merril Pharma Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Merril Pharma Pvt. Ltd (Gujarat) were declared Not of Standard Quality between March 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Merril Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabepra zole Gastro Resistant Tablets IP 20 mg | T-2611 36Mfg 2025-11 · Exp 2027-10 | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab | Jul 2026 |
| Mefenamic Acid & Paracetamol Tablets | T-252174Mfg 2025-03 · Exp 2027-02 | The sample does not conform to Schedule V of the Drugs Rule 1945 with respect to the test disintegration.Disintegration | DTL, ThrissurState lab | Jul 2026 |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP | T5107Mfg 2025-07 · Exp 2027-06 | The sample does not conform to IP with respect to the Test of Dissolution for Glimepiride.Dissolution | CDL, KolkataCDSCO lab | Apr 2026 |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP | T5110Mfg 2025-07 · Exp 2027-06 | The sample does not conform to IP with respect to the test of Dissolution of Glimepiride.Dissolution | CDL, KolkataCDSCO lab | Apr 2026 |
| Luliconazole Cream IP 1% w/w | H017Mfg 2024-04 · Exp 2026-03 | The sample does not conform to I.P 2022 with respect to the content of Luliconazole.Other | CDTL, IndoreCDSCO lab | Oct 2025 |
| Itraconazole Capsules BP 100 mg (Fungis-100) | C4050Mfg 2024-06 · Exp 2026-05 | DissolutionDissolution | CDL, KolkataCDSCO lab | Mar 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.